Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Postoperative Urinary Retention in ENT Surgery
NCT06398899Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2024
- Primary completion
- Jun 2025
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in postoperative urinary retention (POUR) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Postoperative Urinary Retention at 48 hours. Started May 2024; status: completed.
02
Drugs
Sugammadex
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT06398899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06398899.